MNKD Mannkind Corp Losses Due To A Broker?


MannKind Corp. reached a high of about $56 per share in 2014.  From there the stock crashed through all moving averages and showed relative weakness all the way down.  If your broker held this stock and had no exit strategy and failed to limit your losses you may have a valid claim.  Any proper trade plan has risk management and an exit strategy.

Soreide Law Group is representing clients who bought Mannkind Corp., against their financial professionals who recommended MannKind Corp., in large concentrated positions. MNKD may have been unsuitable for some investors and some brokers may have failed to limit losses as the company crashed.  Soreide Law Group has already filed one claim against a National Securities broker for recommending MannKind Corp., to his clients and are interested in speaking with other investors who purchased the stock at any firm with any stock broker.
MannKind Corporation, a biopharmaceutical company, focuses on the discovery, development, and commercialization of therapeutic products for diabetes diseases in the United States. Its approved product is Afrezza, a rapid-acting, inhaled insulin used to control high blood sugar in adults with type 1 and type 2 diabetes.


MNKD Mannkind Corp Losses

MNKD Mannkind Corp Losses

The company was founded in 1991 and is headquartered in Westlake Village, California. MNKD stock hit a high over $50 in July of 2014 and dropped down to under $5 today. That’s an over 90% drop from high to low. Many stock brokers recommended to their clients to stay the course but that was an ill advised strategy that left many with huge stock losses they will never recover from. If you lost more than $50,000 in MannKind Corporation due to your stock brokers recommendation call 888-760-6552. Soreide Law Group is a securities arbitration firm that handles FINRA arbitrations nationwide against financial professionals. If you bought this stock on your own through a self directed trading platform we cannot assist you but if your broker recommended MNKD please contact us today.


2017-10-06T18:41:58+00:00October 6th, 2017|

This site is protected by